ERV3 and related sequences in humans: structure and RNA expression

The ERV3 locus at chromosome 7q11 is a much studied human endogenous retroviral (HERV) sequence, owing to an env open reading frame (ORF) and placental RNA and protein expression. An analysis of the human genome demonstrated that ERV3 is one of a group of 41 highly related elements (ERV3-like HERVs) which use proline, isoleucine, or arginine tRNA in their primer binding sites. In addition to elements closely related to ERV3, the group included the previously known retinoic acid-inducible element, RRHERVI, also referred to as HERV15, but was separate from the related HERV-E elements. The ERV3-like elements are defective. The only element with an ORF among gag, pro, pol, and env genes was the env ORF of the original ERV3 locus. A search in dbEST revealed ERV3 RNA expression in placenta, skin, carcinoid tumor, and adrenal glands. Expression was also studied with newly developed real-time quantitative PCRs (QPCR) of ERV3 and HERV-E(4-1) env sequences. Results from a novel histone 3.3 RNA QPCR result served as the expression control. QPCR results for ERV3 were compatible with previously published results, with a stronger expression in adrenal gland and placenta than in 15 other human tissues. The expression of the envelope (env) of ERV3 at chromosome 7q11 was also studied by using stringent in situ hybridization. Expression was found in corpus luteum, testis, adrenal gland, Hassal's bodies in thymus, brown fat, pituitary gland, and epithelium of the lung. We conclude that ERV3 env is most strongly expressed in adrenal and sebaceous glands as well as in placenta.     

P-Selectin-mediated acute inflammation can be blocked by chemically modified heparin, RO-heparin

Selectins are carbohydrate-binding cell adhesion molecules that play a major role in the initiation of inflammatory responses. Heparin can bind to P-selectin, and its anti-inflammatory property is mainly due to inhibition of P-selectin. However, the strong anticoagulant activity of heparin limits its clinical use. We prepared periodate-oxidized, borohydride-reduced heparin (RO-heparin) by chemical modification and tested its anticoagulant and anti-inflammatory activities. Activated partial thromboplastin time (aPTT) assays showed that, compared with heparin, RO-heparin had greatly reduced anticoagulant activity. Intravenous administration of this compound led to reduction in the peritoneal infiltration of neutrophils in a mouse acute inflammation model. In vitro cell adhesion experiments demonstrated that the effect of RO-heparin on inflammatory responses was mainly due to inhibiting the interaction of P-selectin with its ligands. These results indicate that RO-heparin may be a safer treatment for inflammation than heparin, especially when selectin is targeted.     

A more aggressive breast cancer spheroid model coupled to an electronic capillary sensor system for a high-content screening of cytotoxic agents in cancer therapy: 3-dimensional in vitro tumor spheroids as a screening model

One major problem in cancer therapy is the immortality of tumor cells showing an active telomerase, which is responsible for the elongation of the telomeres after each cellular division and the knocking down of apoptotic suppressors. A further phenomenon occurring during cancer therapies is the problem of multicellular resistance. To develop therapeutic anticancer approaches inducing cellular apoptosis, gene-modified biological in vitro systems were established and evaluated for drug screening in a capillary system for a real-time, impedimertic monitoring. Multicellular spheroids of the human breast cancer cell line T-47D clone 11 were transfected with 1) antisense caspase-3 cDNA expression vectors for knocking down the main cell death molecule and 2) sense Bcl-xl cDNA expression vectors for overexpressing the apoptotic suppressor, resulting in more aggressive tumor models. These gene-modified tumor spheroids less sensitive for apoptosis were developed for screening drugs such as methotrexate in tumor spheroid-based biosensor systems via impedance spectroscopy. In this report, it is demonstrated that this could successfully exhibit that this real-time monitoring system with tumor spheroids positioned in a capillary system with a 4-electrode configuration is the most efficient high-content screening module for impedimetric measurements of physiological alterations during gene modification and drug application.     

Effects of agricultural production on phosphorus losses from paddy soils: a case study in the Taihu Lake Region of China

A field plot experiment was conducted on two types of paddy soils in the Taihu Lake Region of China from June 2000 through 2002 to assess phosphorus (P) losses by runoff and drainage flow and the effectiveness of rice–wheat double cropping on reducing P losses from paddy soils. Commercial NPK compound fertilizer and single superphosphate fertilizer were applied to furnish 0, 30, 150, and 300 kg P ha^–1 for rice season trials, and 0, 20, 80, and 160 kg P ha^–1 for wheat season trials. The experiments consisted of four replicates (plots of 5 × 6 m in a randomized block design) of each treatment in Argic stagnic anthrosols (Anzhen site) and six replicates in Cumulic stagnic anthrosols (Changshu site). P30 and P20 treatments (30 and 20 kg P ha^–1 in rice and wheat seasons, respectively) were considered as conventional P application rates in this area. Higher P treatments, such as P150 and P300 for rice and P80 and P160 for wheat, were intended to simulate the status of soil P in ~10–20 years with an application of P30 or P20 kg P ha^–1 each season. Results revealed that the average concentration of total P (TP) in runoff samples was 0.870 mg P l^–1 from P30 plots during the rice season, and 0.763 mg P l^–1 from P20 plots during the wheat season in both years at the Anzhen site, while it was 0.703 and 1.292 mg P l^–1, respectively, at the Changshu site. Average TP load (mass loss) at the Anzhen site with conventional P application rates was 220.9 and 439.5 g P ha^–1 during rice season in 2000/2001 and 2001/2002, respectively, but was 382.3 and 709.4g P ha^–1 during wheat season, respectively. Mass loss at the Changshu site was 140.4 and 165.7 g P ha^–1 during the rice season and 539.1 and 1184.6 g P ha^–1 during the wheat season, respectively. P losses from paddy soils were significantly greater during the wheat season, especially at the Changshu site, indicating that planting rice reduced P. Phosphate fertilizer levels significantly affected P concentrations and P loads in runoff both seasons. Both mean concentrations and average seasonal P loads from the P150/P80 plots were lower than that from the P300/P160 plots, but significantly higher than that from the P30/P20 and P0 plots. This implied that runoff P loads would be greatly increased in 10–20 years as a result of the accumulation of soil P if 50 kg P ha^–1 (rice season plus wheat season) is applied each year.     

An inhibitor binding pocket distinct from the catalytic active site on human beta-APP cleaving enzyme

Beta-APP cleaving enzyme (BACE) is responsible for the first of two proteolytic cleavages of the APP protein that together lead to the generation of the Alzheimer's disease-associated Abeta peptide. It is widely believed that halting the production of Abeta peptide, by inhibition of BACE, is an attractive therapeutic modality for the treatment of Alzheimer's disease. BACE is an aspartyl protease, and there is significant effort in the pharmaceutical community to apply traditional design methods to the development of active site-directed inhibitors of this enzyme. We report here the discovery of a ligand binding pocket within the catalytic domain of BACE that is distinct from the enzymatic active site (i.e., an exosite). Peptides, initially identified from combinatorial phage peptide libraries, contain the sequence YPYF(I/L)P(L/I) and bind specifically to this exosite, even in the presence of saturating concentrations of active site-directed inhibitors. Binding of peptides to the BACE exosite leads to a concentration-dependent inhibition of proteolysis for APP-related, protein-based substrates of BACE. The discovery of this exosite opens new opportunities for the identification and development of novel and potentially selective small molecule inhibitors of BACE that act through exosite, rather than active site, binding interactions.     

Fluorescence imaging of the activity of glucose oxidase using a hydrogen-peroxide-sensitive europium probe

A method for optical imaging of the activity of glucose oxidase (GOx) using a fluorescent europium(III) tetracycline probe for hydrogen peroxide is presented. A decay time in the microsecond range and the large Stokes shift of 210 nm of the probe facilitate intensity-based, time-resolved, and decay-time-based imaging of glucose oxidase. Four methods for imaging the activity of GOx were compared, and rapid lifetime determination imaging was found to be the best in giving a linear range from 0.32 to 2.7 m Unit/mL. The detection limit is 0.32 m Unit/mL (1.7 ng mL(-1)) which is similar to that of the time-resolved (gated) imaging using a microtiterplate reader. Fluorescent imaging of the activity of GOx is considered to be a useful tool for GOx-based immunoassays with potential for high-throughput screening, immobilization studies, and biosensor array technologies.     

Heme O synthase and heme A synthase from Bacillus subtilis and Rhodobacter sphaeroides interact in Escherichia coli

Cytochrome c oxidase requires multiple heme and copper cofactors to catalyze the reduction of molecular oxygen to water. Although significant progress has been made in understanding the transport and incorporation of the copper ions, considerably less is known about the trafficking and insertion of the heme cofactors. Heme O synthase (HOS) and heme A synthase (HAS) from Rhodobacter sphaeroides (Cox10 and Cox15, respectively) and Bacillus subtilis (CtaB and CtaA, respectively) have been cloned and expressed in Escherichia coli. Our results demonstrate that HOS copurifies with HAS and that HAS copurifies with HOS, indicating that HOS and HAS interact and may form a physiologically relevant complex in vivo. Consistent with this hypothesis, the presence of HAS alters the total level of farnesylated hemes, providing further evidence that HOS and HAS interact. Our current working model is that HOS and HAS form a complex and that heme O is transferred directly from HOS to HAS. Because of the strong sequence similarity and evolutionary relationship between R. sphaeroides and mitochondria, our data suggest that this complex may form in eukaryotes as well.     

直播水稻茎鞘非结构碳水化合物积累与转运的遗传剖析

为了揭示水稻（Oryza sativa）茎鞘非结构碳水化合物（nonstructural carbohydrate, NSC）积累与转运的遗传基础, 在大田直播条件下, 利用来源于Lemont/特青的重组自交系群体, 对5个相关性状进行了QTL定位。始穗期和成熟期共检测到3个茎鞘NSC含量QTL, 分别位于第1、9和12染色体上, 贡献率分别为13%、7%和7%, 增效等位基因均来自特青。检测到的2个NSC转运率QTL均位于第12染色体上, 贡献率分别为8%和14%。检测到的结实率和千粒重QTL分别为3个和4个, 3个结实率QTL的贡献率分别为9%、24%和6%, 4个千粒重QTL的贡献率分别为14%、11%、12%和13%。进一步的分析表明,来自Lemont的等位基因降低成熟期茎鞘NSC含量的同时却能提高NSC转运率、结实率和千粒重, 而来自特青的等位基因对NSC转运率和结实率均有增效作用, 这为性状间表型相关提供了重要的遗传解释。     

丝胶预处理对糖尿病大鼠睾丸IGF-1表达的影响

目的探讨丝胶预处理对2型糖尿病大鼠睾丸胰岛素样生长因子-1(insulin-like growth factor-1,IGF-1)表达的影响。方法 30只雄性SD大鼠随机分为3组(n=10):正常对照组、糖尿病模型组和丝胶预处理组。链脲佐菌素连续腹腔注射制作2型糖尿病大鼠模型,以血糖≥16.7mmol/L作为成模标准;丝胶预处理组大鼠在注射链脲佐菌素前给予丝胶灌胃(2.4g/kg/d)35d。采用葡萄糖氧化酶法检测血糖,采用ELISA方法检测大鼠血清睾酮和IGF-1水平;分别采用免疫组化染色和RT-PCR法检测睾丸IGF-1蛋白和mRNA的表达。结果丝胶预处理可明显抑制糖尿病大鼠血糖升高,血清睾酮、IGF-1水平的降低,睾丸IGF-1表达的下降(丝胶预处理组与糖尿病模型组比较:P0.01)。结果 丝胶预处理可通过阻止糖尿病大鼠睾丸IGF-1表达的下调,改善生精功能,发挥对糖尿病生殖功能损害的预防保护作用。